KBC Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62K | Sell |
6,947
-3,251
| -32% | -$29K | ﹤0.01% | 1482 |
|
|
2025
Q1 | $76K | Hold |
10,198
| – | – | ﹤0.01% | 1624 |
|
|
2024
Q4 | $77K | Buy |
10,198
+4,537
| +80% | +$34.3K | ﹤0.01% | 1691 |
|
|
2024
Q3 | $43K | Sell |
5,661
-2,974
| -34% | -$22.6K | ﹤0.01% | 1765 |
|
|
2024
Q2 | $53K | Buy |
+8,635
| New | +$53K | ﹤0.01% | 1579 |
|